TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Integral Diagnostics Ltd. ( (AU:IDX) ) just unveiled an announcement.
Integral Diagnostics (IDX) announced the upcoming retirement of its Managing Director and CEO, Dr. Ian Kadish, effective at the end of FY26. Dr. Kadish has significantly contributed to the company’s growth, transforming it into the second largest radiology provider in Australia and a notable presence in New Zealand. The company is conducting an international search for his successor, aiming for a seamless transition to maintain service standards and capitalize on recent synergies from its merger with Capitol Health.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services across Australia and New Zealand, employing top radiologists and diagnostic imaging specialists. The company operates under a unique medical leadership model to ensure high-quality patient care and service, positioning itself as a significant player in the radiology sector.
Average Trading Volume: 1,265,662
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$890.1M
For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.